Editorial
Antibiotic Resistance: Have We Become the Dinosaurs?
Abstract
It's been open warfare for approximately half a century, and the news is not good. All of our troops are engaged, the reserves have been mobilized, and we can still barely contain the enemy. Our towns have been infiltrated. The enemy has established pockets everywhere. We do not know when or where it will strike, but we know it will strike again. We are valiantly fending off the latest massive blow, SARS, and are still reeling from the attack of AIDS. Many of our troops are still engaged with the Ebola virus, and others are battling with the West Nile virus.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Cunha BA. Strategies to control antibiotic resistance. Semin Respir Infect 2002; 17: 250–258.
2. Stratton CW. Dead bugs don't mutate: Susceptibility issues in the emergence of bacterial resistance. Emerg Infect Dis 2003; 9: 10–16.
3. Schito GC. Is antimicrobial resistance also subject to globalization? Clin Microbiol Infect 2002; 8 (Suppl 3): 1–8, 33–35.
4. Seaworth BJ. Multidrug-resistant tuberculosis. Infect Dis Clin North Am 2002; 16: 73–105.
5. Arnadottir T. Tuberculosis: Trends and the twenty-first century. Scand J Infect Dis 2001; 33: 563–567.
6. Schluger NW. The impact of drug resistance on the global tuberculosis epidemic. Int J Tuberc Lung Dis 2000; 4 (2 Suppl 1): S71–S75.
7. Cunha BA. Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin Respir Infect 2002; 17: 204–214.
8. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50 (Suppl): 1–5.
9. National Institute of Allergy and Infectious Diseases, National Institutes of Health. Antimicrobial Resistance (NIAID Fact Sheet). Bethesda, MD, U.S. Department of Health and Human Services, June 2000. Available at: http://www.niaid.nih.gov/factsheets/antimicro.htm. Accessed August 6, 2003.
10. Bren L. The battle of the bugs: Fighting antibiotic resistance. FDA Consum 2002Jul-Aug; 36 (4): 28–34.
11. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: Molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002; 2: 180–189.
12. Berger-Bachi B, Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch Microbiol 2002; 178: 165–171.
13. Hiramatsu K, Okuma K, Ma XX, et al. New trends in Staphylococcus aureus infections: Glycopeptide resistance in hospital and methicillin resistance in the community. Curr Opin Infect Dis 2002; 15: 407–413.
14. Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol 2002; 56: 657–675.
15. Hamilton-Miller JM. Vancomycin-resistant Staphylococcus aureus: A real and present danger? Infection 2002; 30: 118–124.
16. U.S. Food and Drug Administration. FDA publishes final rule to require labeling about antibiotic resistance (PO3-07). FDA News, Feb 5, 2003. Available at:http://www.fda.gov/bbs/topics/NEWS/2003/NEW00869.html. Accessed August 6, 2003.
17. Gonzales R. A 65-year-old woman with acute cough illness and an important engagement. JAMA 2003; 289: 2701–2708.
18. Butaye P, Devriese LA, Haesebrouck F. Antimicrobial growth promoters used in animal feed: Effects of less well known antibiotics on Gram-positive bacteria. Clin Microbiol Rev 2003; 16: 175–188.
19. van den Bogaard AE, Stobberingh EE. Epidemiology of resistance to antibiotics: Links between animals and humans. Int J Antimicrob Agents 2000; 14: 327–335.
20. Teale CJ. Antimicrobial resistance and the food chain. J Appl Microbiol 2002; 92 (Suppl): 85S–89S.
21. Bren L. Antibiotic resistance from down on the chicken farm. FDA Consum 2001Jan-Feb; 35 (1): 10–11.
22. U.S. Department of Health and Human Services. HHS releases action plan to combat antimicrobial resistance (Press Release). Washington, DC, U.S. Department of Health and Human Services, January 18, 2001. Available at: http://www.hhs.gov/news/press/2001pres/20010118b.html. Accessed August 6, 2003.
23. Interagency Task Force on Antimicrobial Resistance. A Public Health Action Plan to Combat Antimicrobial Resistance. Washington, DC, U.S. Department of Health and Human Services. Available at: http://www.cdc.gov/drugresistance/actionplan/aractionplan.pdf. Accessed August 8, 2003.
24. Center for Veterinary Medicine, U.S. Food and Drug Administration. National Antimicrobial Resistance Monitoring System (NARMS). Rockville, MD, Center for Veterinary Medicine, U.S. Food and Drug Administration, U.S. Department of Health and Human Services. Available at:http://www.fda.gov/cvm/INDEX/narms/narms_pg.html. Accessed August 6, 2003.
25. McCracken GH Jr. Clinical practice guidelines for the diagnosis and treatment of respiratory tract infections. Am J Manag Care 2001; 7 (6 Suppl): S183–S191.
26. Dalhoff K. Worldwide guidelines for respiratory tract infections: Community-acquired pneumonia. Int J Antimicrob Agents 2001; 18 (Suppl 1): S39–S44.
27. Gross PA, Pujat D. Implementing practice guidelines for appropriate antimicrobial usage: A systematic review. Med Care 2001; 39 (8 Suppl 2): II55–II69.
28. Al-Ghnaniem R, Benjamin IS, Patel AG. Meta-analysis suggests antibiotic prophylaxis is not warranted in low-risk patients undergoing laparoscopic cholecystectomy. Br J Surg 2003; 90: 365–366.
